Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Red de Terapia Celular
With
Spanish National Health System
Hospital Universitario Virgen de la Arrixaca
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Public Health Service, Murcia
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of definite or probable ALS according to the criteria established by the World Federation of Neurology
Patient that provides reasonable assurance of adherence to protocol.
Neurophysiological data confirming affectation of lower motor neurons in the lumbar region.
Assessment of motor deficits in dorsiflexion of both feet (4 or 5 points on the MRC scale)
You may not be if
Diabetes Mellitus.
Other diseases that may present with polyneuropathy.
Previous history of stroke.
Prior Pathology of the peripheral nervous system affecting one or both lower limbs with or without clinically evident neurological sequelae.
Pregnant or breastfeeding patients active.
Patients physiologically capable of becoming pregnant, unless they are using reliable contraception.
Patients with cardiac disease, renal, hepatic, systemic, immune that may influence patient survival during the test.
Positive serology for hepatitis B, hepatitis C or HIV.
Clinical and anesthesiologic Criteria, contraindicating either sedation or extraction of MO (Altered coagulation system or anticoagulated patient with inability to withdraw anticoagulation, hemodynamic instability, altered skin puncture site, etc.)
Included in other clinical trials in the last 6 months.